CAMBRIDGE, Mass., May 20, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clin...
Mersana Therapeutics, Inc. (NASDAQ:MRSN – Free Report) – Stock analysts at Wedbush boosted their Q2 ...
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Goo...
Mersana Therapeutics (NASDAQ:MRSN – Get Free Report) announced its quarterly earnings results on Thu...
Mersana Therapeutics Inc (MRSN) extends cash runway and reports promising clinical data, despite inc...